Patents Assigned to Lifeline Scientific, Inc.
  • Patent number: 8323954
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: December 4, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: David C. Kravitz, John Brassil, Kelvin G. M. Brockbank, Andrew Burroughs, Dickon Isaacs, Douglas Schein
  • Patent number: 8318415
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: November 27, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G. M. Brockbank, Andrew Burroughs, Dickon Isaacs, Dennis J Steibel, Richard Fraser, Stanley Harris, Douglas Schein, Christopher G. Curtis
  • Publication number: 20120276519
    Abstract: Disclosed is a cannula including a first clamping portion, a second clamping portion and a force applying portion configured to apply at least two different clamping forces across the first clamping portion and the second clamping portion when the cannula is in a closed state. The first clamping portion includes a first gear, the second clamping portion includes a second gear, and the first gear and the second gear are in meshing engagement.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 1, 2012
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: David Kravitz, Christopher Steinman, David Pettinato
  • Publication number: 20120276620
    Abstract: Disclosed is portable organ transportation system including a mobile cart and an organ container. At least one of the mobile cart and the organ container include a latch for releasably attaching the organ container to the mobile cart. The organ container may be a portable organ preservation device or a portable organ perfusion apparatus.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 1, 2012
    Applicant: Lifeline Scientific, Inc.
    Inventors: David Kravitz, Aaron Randall Ferber, Ross Lockwood, Rodney Hal Monson, Evan David Shapiro
  • Publication number: 20120277687
    Abstract: Disclosed is a cannula including a first circumferential portion, a second circumferential portion, and a seal with a first clamping surface. The first circumferential portion and the second circumferential portion are configured to mutually cooperate to support a circumference of vasculature, and form a second clamping surface. The first clamping surface and the second clamping surface are configured to cooperate to secure an end of the vasculature.
    Type: Application
    Filed: April 29, 2011
    Publication date: November 1, 2012
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: David Kravitz, Christopher Steinman, David Pettinato
  • Publication number: 20120277681
    Abstract: A cannula includes a first circumferential portion, a second circumferential portion, and a seal with a first clamping surface. The first circumferential portion and the second circumferential portion are configured to mutually cooperate to support a circumference of vasculature, and form a second clamping surface. The first clamping surface and the second clamping surface are configured to cooperate to secure an end of the vasculature.
    Type: Application
    Filed: October 27, 2011
    Publication date: November 1, 2012
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: David Kravitz, Christopher Steinman, David Pettinato
  • Patent number: 8268612
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Grant
    Filed: August 10, 2011
    Date of Patent: September 18, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G. M. Brockbank, Andrew Burroughs, Douglas Schein, Dickon Isaacs
  • Patent number: 8268547
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In perfusion, organ perfusion pressure is preferably controlled in response to a sensor disposed in an end of tubing placed in the organ, by a pneumatically pressurized medical fluid reservoir, providing perfusion pressure fine tuning, overpressurization prevention and emergency flow cut-off.
    Type: Grant
    Filed: October 25, 2005
    Date of Patent: September 18, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: Donald R. Owen, David C. Kravitz
  • Publication number: 20120148542
    Abstract: Methods for perfusing one or more organs, tissues or the like (hereinafter “organs”) with a composition comprising at least one complement inhibitor to sustain, maintain or improve the viability of the organs before and/or during transplantation.
    Type: Application
    Filed: December 9, 2011
    Publication date: June 14, 2012
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventor: David KRAVITZ
  • Publication number: 20120015343
    Abstract: Methods of isolating cellular products, such as pancreatic islets, may be used in diabetes research and therapeutic transplantation. The methods may involve providing a donor tissue having desired cells and undesired cells, perfusing the donor tissue with a perfusion solution, developing edema during perfusion of the donor tissue to form a swelled tissue, and separating the desired cells from undesired cellular material to obtain a cellular product. The methods may also include disrupting the tissue, and separating the desired cells from undesired cellular material to obtain the cellular product. The methods may result in an increased yield of cellular product that retains sufficient functional integrity to be useful as a transplantation resource.
    Type: Application
    Filed: July 15, 2011
    Publication date: January 19, 2012
    Applicants: CELL & TISSUE SYSTEMS, INC., LIFELINE SCIENTIFIC, INC.
    Inventors: Michael J. TAYLOR, Simona C. BAICU, David KRAVITZ
  • Publication number: 20110300612
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Application
    Filed: August 10, 2011
    Publication date: December 8, 2011
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G.M. Brockbank, Andrew Burroughs, Dickon Isaacs, Dennis J. Steibel, Richard Fraser, Stanley Harris, Douglas Schein
  • Publication number: 20110300613
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Application
    Filed: August 10, 2011
    Publication date: December 8, 2011
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G.M. Brockbank, Andrew Burroughs, Dickon Isaacs, Dennis J. Steibel, Richard Fraser, Santley Harris, Douglas Schein
  • Publication number: 20110300614
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Application
    Filed: August 10, 2011
    Publication date: December 8, 2011
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G.M. Brockbank, Andrew Burroughs, Dickon Isaacs, Dennis J. Steibel, Richard Fraser, Stanley Harris, Douglas Schein
  • Publication number: 20110300611
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Application
    Filed: August 10, 2011
    Publication date: December 8, 2011
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G.M. Brockbank, Andrew Burroughs, Dickon Isaacs, Dennis J. Steibel, Richard Fraser, Stanley Harris, Douglas Schein
  • Publication number: 20110183310
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Application
    Filed: March 29, 2011
    Publication date: July 28, 2011
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: David C. Kravitz, John Brassil, Kelvin G.M. Brockbank, Andrew Burroughs, Dickon Isaacs, Douglas Schein
  • Publication number: 20110129908
    Abstract: An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. The method includes perfusing the organ at hypothermic and/or normothermic temperatures, preferably after hypothermic organ flushing for organ transport and/or storage. The method can be practiced with prior or subsequent static or perfusion hypothermic exposure of the organ. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures.
    Type: Application
    Filed: January 21, 2011
    Publication date: June 2, 2011
    Applicant: LIFELINE SCIENTIFIC, INC.
    Inventors: Donald R. Owen, David C. Kravitz, John Brassil, Kelvin G.M. Brockbank, Andrew Burroughs, Dickon Isaccs, Douglas Schein
  • Patent number: D655063
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: February 28, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: David Kravitz, Aaron Randall Ferber, Ross Lockwood, Rodney Hal Monson, Evan David Shapiro
  • Patent number: D664261
    Type: Grant
    Filed: January 11, 2012
    Date of Patent: July 24, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: David C. Kravitz, Peter Demuylder, Brian Otts, Stephan Merkle, Jeremiah P. O'Leary, Christopher E. Svensrud
  • Patent number: D671653
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: November 27, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: David Kravitz, Aaron Randall Ferber, Ross Lockwood, Rodney Hal Monson, Evan David Shapiro
  • Patent number: D672466
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: December 11, 2012
    Assignee: Lifeline Scientific, Inc.
    Inventors: David Kravitz, Aaron Randall Ferber, Ross Lockwood, Rodney Hal Monson, Evan David Shapiro